Related Experiment Video
Updated: Sep 9, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.7K
THE IMPACT OF DISEASE-MODIFYING MEDICATIONS ON THE LIPID PROFILE OF PATIENTS WITH ISCHEMIC HEART DISEASE
N Mohammad1, O Darweesh2, M Merkhan3
11Department of Pharmacy, Al-Qalam University College, Kirkuk, Iraq.
Georgian Medical News
|August 30, 2025
Summary
Combination therapy with disease-modifying medications significantly reduces lipid parameters in patients with ischemic heart disease (IHD). This approach offers a valuable strategy for managing IHD risk factors like myocardial infarction (MI) and stroke.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Ischemic heart diseases (IHD) involve coronary artery narrowing, increasing risks of myocardial infarction (MI) and stroke.
- High morbidity and mortality associated with IHD pose significant healthcare challenges.
Purpose of the Study:
- To evaluate the role of disease-modifying medications (DMMs) in managing IHD risk factors.
- Specific DMMs investigated include statins, SGLT2 inhibitors, and PCSK9 inhibitors.
Main Methods:
- A randomized controlled trial involving 500 patients across four treatment groups: statins, SGLT2 inhibitors, PCSK9 inhibitors, and combination therapy.
- Serum lipid parameters were assessed at baseline and 12 months post-treatment.
Main Results:
- All treatment groups showed a reduction in lipid parameters after 12 months.
- Combination therapy yielded the most significant lipid reduction (-74±10 mg/dL, p<0.05).
- Age and gender showed minor modulation of treatment response.
Conclusions:
- Combination DMM therapy is a promising strategy for managing lipid parameters in IHD patients.
- This approach may reduce risks of stroke and MI, offering an additional therapeutic role in cardiovascular disease management.
Related Concept Videos
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29